Krejcik, J., Casneuf, T., Nijhof, I. S., Verbist, B., Bald, J., Plesner, T., . . . Sasser, A. K. (2016). Daratumumab depletes CD38(+) immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma. Blood.
シカゴスタイル引用形Krejcik, Jakub, et al. "Daratumumab Depletes CD38(+) Immune Regulatory Cells, Promotes T-cell Expansion, and Skews T-cell Repertoire in Multiple Myeloma." Blood 2016.
MLA引用形式Krejcik, Jakub, et al. "Daratumumab Depletes CD38(+) Immune Regulatory Cells, Promotes T-cell Expansion, and Skews T-cell Repertoire in Multiple Myeloma." Blood 2016.
警告: この引用は必ずしも正確ではありません.